Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports
Loading feed
KPMG is a global network of professional services firms providing Audit, Tax and Advisory services. We operate in 147 countries and territories and have more than 219,000 people working in member firms around the world. KPMG’s Private Equity group in China provides end to end advisory and assurance services to private equity funds, venture capital funds, private credit funds, sovereign wealth and other direct investment managers. Moreover, to augment this, KPMG China and its member firms have established focused industry groups covering areas in which we have particular knowledge. Not exhaustive, but we have sector capabilities focused on Consumer Markets, Financial Services, Government, Healthcare, Industrials, Infrastructure, Logistics, Pharmaceuticals and TMT.
Learn more at: https://home.kpmg/cn/en/home/industries/private-equity.html
WeChat: http://weixin.qq.com/r/A0Po8PrE_aeGrb6T9xYR
Weibo: https://weibo.com/kpmgchina
YouTube: https://www.youtube.com/user/kpmgchinahk
CCV Capital is a global venture capital firm deeply rooted in the Silicon Valley ethos, specializing in early-stage investments while upholding the esteemed legacy of KPCB. Founded by Wei Zhou, the former Managing Partner of KPCB China, alongside the original technology investment team, we seamlessly merge Silicon Valley’s innovative spirit with a broad global presence. We operate from offices in Singapore, Silicon Valley, and Beijing, investing in pioneering global technologies.
With assets under management approaching $2 billion, our founding team leverages extensive entrepreneurial expertise to identify and cultivate high-potential startups. Within our first decade, we achieved a 35% unicorn formation rate and led Series A rounds for 80% of our ventures, elevating many to become trailblazers in their sectors and achieve successful public offerings.
Our prestigious portfolio includes notable companies such as JD.com (NASDAQ:JD), VenusTech (002439), CreditEase (NYSE:YRD), Rong360 (NYSE:JT), Arrail Dental (HKSE:06639), SYS Water Doctor (301372), and TanTan (acquired by NASDAQ:MOMO). We also back innovators like Ximalaya FM, Shukun Technology, JD Digital, Transsnet Financial, MetaApp, U POWER, Cowa Robot, and IceKredit.
CCV Capital's Partners have been repeatedly recognized in Forbes' Top 100 Most Influential Global Chinese and Top 30 Venture Capitalists, included in Fortune's Top 30 Most Influential Investors of the Year, and has received numerous accolades, including Best Venture Capitalist by China Venture and Best Technology Fund Manager by The Asset. Additionally, CCV Capital has been consistently acknowledged as a leading venture capital firm globally.
East Ventures is a pioneering and leading sector-agnostic venture capital firm. Founded in 2009, East Ventures has transformed into a holistic platform that provides multi-stage investment, from Seed to Growth stage investments, for over 300 tech companies across Southeast Asia.
As an early believer in the startup ecosystem in Indonesia and the most active investor in Southeast Asia, East Ventures is an early backer of prominent tech companies in the region, such as Tokopedia, Traveloka, Ruangguru, ShopBack, waresix, Xendit, IDN, Sociolla, Fore Coffee, Tech in Asia (acquired by SPH), Kudo (acquired by Grab), Loket (acquired by Gojek), and MokaPOS (acquired by Gojek).
East Ventures was named the most consistent top-performing VC fund globally by Preqin and the most active investor in SEA and Indonesia by various media. Moreover, East Ventures is Indonesia's first venture capital firm to sign the Principles of Responsible Investment (PRI), supported by the United Nations (UN). East Ventures is committed to achieving sustainable development and positively impacting society through its initiatives and ESG-embedded practices.
Globis Capital Partners is one of Japan's leading independent venture capital firm that primarily invests in Japanese startups from early stage to pre-IPO stage. Globis has managed seven funds totaling over JPY 180 billion, including latest Globis VII (final closed in March 2023 at JPY 72.7billion). All closed funds were ranked in the top quartile in global VC benchmarks in their respective vintage years, and it has multiple unicorn and unicorn potential startups in its current portfolio. About 90% of LPs are institutional investors both from and outside of Japan. 
Globis almost always leads rounds and provides hands-on management support to its portfolio companies through board participation by its capitalists as well as tactical support by its value-add team GCP X. In addition, in April 2023 Globis opened a new office in San Francisco to strengthen support for the global expansion of its portfolio companies.
With its unique combination of western style investment expertise obtained through a joint venture with Apax Partners and Japan-local business expertise through Globis Group, which runs No.1 MBA program in Japan, Globis continues to lead the VC market in Japan.
Founded on July 1, 2019, INCE Capital is a venture capital firm with an investment focus on early to expansion stage companies that spearhead innovation in technology, Internet, and consumer industries.
The letters “IN” embody the firm’s commitment to make intelligent innovative investment decision, or “CE” in Chinese. INCE’s mission is to “empower the future greats”.
INCE now has more than US$1 billion in commitments under management across its managed funds. The investor base consists of the world’s leading university endowments, foundations, family offices, and funds of funds.
INCE closed its first fund in October 2019, raising a total of $351,888,000, and announced the final closing of its second US dollar-denominated fund with around US$700 million in commitments across two funds in January 2022.
INCE’s founding partners, JP Gan, Steven Hu, Stella Zhou and Paul Keung are supported by teams in Shanghai, Beijing, and Hong Kong, China.
MSA Capital is a global private equity and venture capital firm founded in 2014 that focuses on early and growth stage investments. The firm manages over USD 2 billion and invests in highly innovative and disruptive companies in the biotech, core tech, and consumer sectors. Notable portfolio companies include Meituan, Boss Zhipin, NIO, BGI, Yidu Cloud, Cloudr, Pyrotech, Cider, and Sironax. MSA’s LP base composed of regional and global institutional investors, as well as leading entrepreneurs from China.
TH Capital was founded in 2007 as part of Tsinghua University ecosystem in Beijing. Owned and managed by the founding partners, the company has become a leading GP in China, investing growth capital in China’s most innovative and advanced high-tech companies. To date, TH Capital has invested minority shares in over 100 rapidly growing and highly profitable hard-tech companies across China, financing their development in their home market and beyond.
Based on 15 years of track record as an investor in industrial high-tech, our investment focus and ability are aligned with China’s top-level development goals, concentrating on Advanced Manufacturing, Next-Generation Technologies, Decarbonization and Frontier Technologies.
Investors in TH Capital’s funds include leading private market asset managers and financial institutions from China and abroad. Our 50 investment and research professionals execute our investment model based on proprietary in-house top-down industry research and unique resources of the Tsinghua ecosystem. With China Roots and a global vision, we have built strong value-add capabilities in China and abroad, supporting portfolio companies from offices in Beijing, Shenzhen and Zurich. Understanding the regulatory impact and strategic direction of China, TH Capital has developed an investment model investing across China’s strategic high-tech industries and exits its investment through IPOs on the stock exchanges in China.
With AUM exceeding RMB 20bn across 5 funds raised, TH Capital is raising its first USD fund in 2023 to provide international investors with unique access to the biggest growth investment opportunities across China’s high-tech industries.
Founded in 2000, TTGG Ventures is one of the longest-running domestic fund managers in China. With over $1.3 billion in assets under management, TTGG capitalizes on opportunities in manufacturing, technology, and healthcare amidst China's structural transformation.
As of 2023, our investments have reached $3.28 billion, and 50 portfolio companies have successfully gone public. Our seasoned investment team, with over two decades of experience, delivers unparalleled market acumen and a forward-looking approach. Notably, we identified and began investing in the New Energy sector as early as 2014, placing us at the vanguard of industry shifts.
Demonstrating consistent outperformance, TTGG has maintained its position among the top quartile of RMB funds, particularly excelling in DPI over the past decade.
Cooley LLP is an international law firm representing clients in a wide range of industries. Cooley has more than 1,500 lawyers across 17 offices in Asia, Europe and the United States. The firm represents 6,000+ high-growth new economy companies, 500+ venture fund families and closes over 2,000 venture and growth investments per year.
In Asia, Cooley has offices in Beijing, Shanghai, Hong Kong and Singapore. Cooley is broadly recognized for its powerhouse technology, life sciences and venture capital practices. We represent some of Asia’s most innovative and dynamic companies and leading investors, advising on their financings, M&As and joint ventures, IPOs and other strategic transactions at all stages of their growth.
Our dedication to Asia's fund industry is unparalleled and unrivaled by any other law firm. Cooley has been advising on Asia-related matters over three decades, dating back to 1989, when the firm advised on the formation of the first institutional venture capital fund investing in China. Today, we are counsel to more than 500 private investment fund organizations worldwide, including more than 90 fund managers with their primary operations in China and other Asia countries and numerous other managers outside of the region making investments in portfolio companies in Asia. We form considerably more dollar-denominated Asia venture capital and growth equity funds in dollar terms than any other law firm worldwide. We have a team of more than 40 specialist fund formation lawyers and dozens of other practitioners dedicated to serving our clients headquartered and doing business in Asia. Multiple members of our team are Mandarin-speaking, Chinese native fund formation specialists who assist our China funds clients and their investors in both USD and RMB fund formation matters.
An error occurred trying to play the stream. Please reload the page and try again.
CloseTim Burroughs is managing editor of Asian Venture Capital Journal, having joined the publication in May 2011. He is responsible for all editorial content put out under the AVCJ brand, including Asian Venture Capital Journal, AVCJtv, AVCJ Awards and AVCJ.com. Tim previously spent five years at China Economic Review, serving as editor-in-chief and then editorial director. Located in Greater China since 2003, during which time he has lived in Beijing, Qingdao and Hong Kong, Tim has been a China-based contributor for publications including The Sunday Times, Sunday Telegraph, BBC and China Daily. Prior to moving to China, he trained and worked as a journalist in the UK. He was honored at the Society of Publishers in Asia awards in 2007, 2008 and 2010, and at the State Street Institutional Press Awards - Asia in 2012.
Weijian Shan is the executive chairman and co-founder of PAG – an Asia-based and focused private equity firm with more than USD50 billion in capital under management.
Between 1998 and 2010, he was co-managing partner of the private equity firm Newbridge Capital (now known as TPG Asia) and a partner of TPG. Shan was a managing director of JP Morgan, where he was concurrently the chief representative for China between 1993 and 1998. He was an assistant professor at the Wharton School, the University of Pennsylvania between 1987 and 1993. He also worked at the World Bank in 1987 as a member of its Young Professionals Program.
Shan is a Trustee of the British Museum. He is also a member of the International Advisory Council of Hong Kong Exchanges and Clearing Limited, and an independent director of Alibaba Group.
Shan is the author of Out of the Gobi: My Story of China and America (2019), Money Games: The Inside Story of How American Dealmakers Saved Korea's Most Iconic Bank (2021) and Money Machine – A Trailblazing American Venture in China (February 2023). He has published commentaries in the likes of The New York Times, the Wall Street Journal, the Financial Times, the Economist and Foreign Affairs.
Shan holds an M.A. and a Ph.D. from the University of California, Berkeley, and an M.B.A. from the University of San Francisco. He graduated with a major in English from the Beijing University of International Business and Economics.